Drug Profile
TZN 13
Alternative Names: Estradiol transdermal - Teikoku HormoneLatest Information Update: 14 May 2008
Price :
$50
*
At a glance
- Originator Teikoku Hormone
- Class Antineoplastics; Estradiol congeners; Estrenes; Hormonal replacements
- Mechanism of Action Estrogen receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Menopausal syndrome; Postmenopausal osteoporosis
Most Recent Events
- 30 May 2005 No development reported - Phase-II for Menopausal syndrome in Japan (Transdermal)
- 30 May 2005 No development reported - Phase-II for Postmenopausal osteoporosis in Japan (Transdermal)
- 30 Jan 2001 Phase-II clinical trials for Menopausal syndrome in Japan (Transdermal)